インスリン送達デバイス市場：製品別、エンドユーザー別-2025-2030年の世界予測

インスリン送達デバイス市場は、2023年に285億5,000万米ドルと評価され、2024年には306億1,000万米ドルに達すると予測され、CAGR 8.00%で成長し、2030年には489億3,000万米ドルに達すると予測されています。

インスリン送達デバイス市場には、糖尿病患者にインスリンを投与するための幅広い製品が含まれます。これらのデバイスには、シリンジ、インスリンペン、インスリンポンプ、ジェットインジェクターなどがあり、それぞれ異なる患者のニーズや嗜好に対応しています。このようなデバイスの必要性は、人口の高齢化、ライフスタイルの変化、肥満率の増加により、糖尿病有病率が世界的に上昇していることに起因しています。インスリン送達デバイスは1型糖尿病と2型糖尿病の両方の管理に使用され、エンドユーザーは個人、ヘルスケアプロバイダー、病院です。この市場の成長は、糖尿病管理に対する意識の高まり、患者の利便性を高める機器設計の技術的進歩、在宅ヘルスケアソリューションへの注目の高まりによってもたらされます。新たなビジネスチャンスは、スマートインスリンペンとインスリンポンプと持続的グルコースモニタリングを統合したクローズドループシステムの採用拡大にあります。これらの技術革新は血糖コントロールを大幅に向上させ、市場関係者に大きなビジネスチャンスをもたらします。しかし、高コスト、限られた償還政策、先進デバイスの安全性への懸念といった課題が市場拡大の妨げとなっています。さらに、新規機器の承認に関する規制上のハードルが障壁となっています。こうした課題にもかかわらず、同市場は、特にインスリン投与における予測分析のための人工知能と機械学習の統合において、技術革新の大きな可能性を提供しています。また、デジタルヘルスプラットフォームとの接続性を拡大することで、新たなビジネスの道も開ける可能性があります。調査は、デバイスの使い勝手の向上とインスリン送達システムの精度向上に焦点を当てることができます。ナノ送達技術や生物学的に統合されたデバイスの進歩は、患者のアドヒアランスと転帰をさらに大きく変える可能性があります。市場参入企業は、成長を継続させるために患者中心のソリューションでイノベーションを実現する必要があり、競争は続いています。地域のヘルスケア政策、患者の人口統計を分析し、大規模試験のために医療施設と協力することで、市場シェアを獲得・拡大するための実用的な洞察を得ることができ、包括的な理解を確保し、患者のニーズに効果的に対応することができます。

市場力学：急速に進化するインスリン送達デバイス市場の主要市場インサイトを公開

インスリン送達デバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の増加とインスリン送達のための先進デバイスの採用
  • 世界中で増加する糖尿病人口と肥満人口
  • 最新のインスリン送達デバイスに関する消費者意識の高まり
• 市場抑制要因
  • インスリン送達デバイスの高コストと保険適用不足
• 市場機会
  • インスリン送達デバイスの技術的進歩
  • 自動化されたインスリン送達デバイスのイントロダクション
• 市場の課題
  • 厳格化する政府規則と複雑な製品承認プロセス

ポーターのファイブフォース：インスリン送達デバイス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、インスリン送達デバイス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：インスリン送達デバイス市場における外部からの影響の把握

外部マクロ環境要因は、インスリン送達デバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析インスリン送達デバイス市場における競合情勢の把握

インスリン送達デバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスインスリン送達デバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、インスリン送達デバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨インスリン送達デバイス市場における成功への道筋を描く

インスリン送達デバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の増加とインスリン投与のための先進機器の導入
    • 世界中で糖尿病と肥満人口が増加
    • 最新のインスリン送達デバイスに関する消費者の意識の高まり
  • 抑制要因
    • インスリン送達デバイスのコストが高く、保険の適用範囲が狭い
  • 機会
    • インスリン送達デバイスにおける技術的進歩
    • 自動化されたインスリン送達デバイスのイントロダクション
  • 課題
    • 政府の規制の厳格化と製品承認プロセスの複雑化
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 インスリン送達デバイス市場：製品別

• インスリン注射器
• インスリンペン
• インスリンポンプ
• インスリン注射器

第7章 インスリン送達デバイス市場：エンドユーザー別

• ホームケア
• 病院

第8章 南北アメリカのインスリン送達デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のインスリン送達デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのインスリン送達デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Baxter International Inc
• Becton, Dickinson and Company
• Biocon Ltd.
• Braun Melsungen AG
• Bristol-Myers Squibb Company
• Daiichi Sankyo Company, Ltd.
• Dr Reddy's Laboratories Ltd
• Eli Lilly and Company
• F. Hoffmann-La Roche, Ltd.
• Insulet Corporation
• Johnson & Johnson
• Medtronic PLC
• Merck & Co., Inc.
• Novo Nordisk A/S
• Sanofi SA
• Tandem Diabetes Care, Inc.
• TOPAS Advanced Polymers GmbH
• Ypsomed AG
• Zealand Pharma A/S

LIST OF FIGURES

• FIGURE 1. INSULIN DELIVERY DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. INSULIN DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. INSULIN DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. INSULIN DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INSULIN DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INSULIN DELIVERY DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN INJECTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. POLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. POLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. INSULIN DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. INSULIN DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Insulin Delivery Devices Market was valued at USD 28.55 billion in 2023, expected to reach USD 30.61 billion in 2024, and is projected to grow at a CAGR of 8.00%, to USD 48.93 billion by 2030.

The insulin delivery devices market encompasses a wide range of products designed to administer insulin to individuals with diabetes. These devices include syringes, insulin pens, insulin pumps, and jet injectors, each catering to different patient needs and preferences. The necessity for such devices stems from the global rise in diabetes prevalence, compounded by aging populations, lifestyle changes, and increasing obesity rates. Insulin delivery devices are employed in both Type 1 and Type 2 diabetes management, with end-users comprising individuals, healthcare providers, and hospitals. Growth in this market is driven by heightened awareness of diabetes management, technological advancements in device design enhancing patient convenience, and a stronger focus on home healthcare solutions. Emerging opportunities lie in the increasing adoption of smart insulin pens and closed-loop systems that integrate continuous glucose monitoring with insulin pumps. These innovations can significantly enhance glycemic control, presenting substantial opportunities for market players. However, challenges such as high costs, limited reimbursement policies, and safety concerns of advanced devices hamper market expansion. Additionally, regulatory hurdles for new device approvals pose barriers. Despite these challenges, the market offers significant potential for innovation, particularly in the integration of artificial intelligence and machine learning for predictive analytics in insulin administration. Expanding device connectivity with digital health platforms can also offer new business avenues. Research can focus on enhancing the user-friendliness of devices and improving the precision of insulin delivery systems. Advancements in nano-delivery technologies and biologically integrated devices may further revolutionize patient adherence and outcomes. The market remains competitive, with participants needing to align innovations with patient-centric solutions to continue fostering growth. Analyzing regional healthcare policies, patient demographics, and collaborating with healthcare facilities for large-scale trials can provide actionable insights into capturing and expanding market shares, ensuring a comprehensive understanding and addressing patient needs effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Insulin Delivery Devices Market

The Insulin Delivery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing chronic diseases and adoption of advanced devices for insulin delivery
  • Increasing diabetic & obese population across the globe
  • Rising consumer awareness about the latest insulin delivery devices
• Market Restraints
  • High cost of insulin delivery devices and lack of insurance coverage
• Market Opportunities
  • Technological advancements in insulin delivery devices
  • Introduction of automated insulin delivery devices
• Market Challenges
  • Increasing stringent government rules and complicated product approval process

Porter's Five Forces: A Strategic Tool for Navigating the Insulin Delivery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Insulin Delivery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Insulin Delivery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Insulin Delivery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Insulin Delivery Devices Market

A detailed market share analysis in the Insulin Delivery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Insulin Delivery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Insulin Delivery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Insulin Delivery Devices Market

A strategic analysis of the Insulin Delivery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Insulin Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Baxter International Inc, Becton, Dickinson and Company, Biocon Ltd., Braun Melsungen AG, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Ltd., Dr Reddy's Laboratories Ltd, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Insulet Corporation, Johnson & Johnson, Medtronic PLC, Merck & Co., Inc., Novo Nordisk A/S, Sanofi SA, Tandem Diabetes Care, Inc., TOPAS Advanced Polymers GmbH, Ypsomed AG, and Zealand Pharma A/S.

Market Segmentation & Coverage

This research report categorizes the Insulin Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Insulin Injectors, Insulin Pens, Insulin Pumps, and Insulin Syringes.
• Based on End-User, market is studied across Homecare and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing chronic diseases and adoption of advanced devices for insulin delivery
    • 5.1.1.2. Increasing diabetic & obese population across the globe
    • 5.1.1.3. Rising consumer awareness about the latest insulin delivery devices
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of insulin delivery devices and lack of insurance coverage
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in insulin delivery devices
    • 5.1.3.2. Introduction of automated insulin delivery devices
  • 5.1.4. Challenges
    • 5.1.4.1. Increasing stringent government rules and complicated product approval process
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Insulin Delivery Devices Market, by Product

• 6.1. Introduction
• 6.2. Insulin Injectors
• 6.3. Insulin Pens
• 6.4. Insulin Pumps
• 6.5. Insulin Syringes

7. Insulin Delivery Devices Market, by End-User

• 7.1. Introduction
• 7.2. Homecare
• 7.3. Hospitals

8. Americas Insulin Delivery Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Insulin Delivery Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Insulin Delivery Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Baxter International Inc
• 3. Becton, Dickinson and Company
• 4. Biocon Ltd.
• 5. Braun Melsungen AG
• 6. Bristol-Myers Squibb Company
• 7. Daiichi Sankyo Company, Ltd.
• 8. Dr Reddy's Laboratories Ltd
• 9. Eli Lilly and Company
• 10. F. Hoffmann-La Roche, Ltd.
• 11. Insulet Corporation
• 12. Johnson & Johnson
• 13. Medtronic PLC
• 14. Merck & Co., Inc.
• 15. Novo Nordisk A/S
• 16. Sanofi SA
• 17. Tandem Diabetes Care, Inc.
• 18. TOPAS Advanced Polymers GmbH
• 19. Ypsomed AG
• 20. Zealand Pharma A/S